FDG-PET: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving FDG-PET

• Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
  NCT03019757 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer
  NCT06335914 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism
  NCT06079294 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma
  NCT06833229 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
  NCT06648317 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve FDG-PET?

5 recruiting trials across 11 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.